Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • Aman Pant Ignites Sensational Musical Spectacle for Netflix’s Guns and Gulaabs Entertainment
  • IDRC’s 4th Arbitration in India Conclave 2025: We will Strengthen Institutional Arbitration, Law Min. Meghwal National
  • Growth Biz: India’s First Global B2B Offline Hypermarket Revolutionizes Business Opportunities Business
  • Task Tracker: A Free Interactive Web and Mobile App To Simplify People Management Across Teams Business
  • KalonGens, Start-up by Former Boxer Keshav, provides Unbeatable Talent-Powered Solutions For Advance Business Success Business
  • Cultural activist Sundeep Bhutoria calls for Social Investment Policy for Non-resident Rajasthanis at Pravasi Rajasthan Divas 2025 in Jaipur National
  • GVFL and Brinc Enter Strategic Partnership to Launch Multi-sector Startup Accelerator Business
  • Rapidly rising leader in real estate Mangal Buildhome wins Times Achievers 2022 Business

Dr. Yukata Niihara felicitated by Honourable Minister of State, Shri Arun Halder for developing FDA- approved drug ENDARI to fight SCD

Posted on December 16, 2022 By

Dr. Yukata Niihara was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable  Minister of State, Shri Arun Halder

New Delhi, December 16: Dr. Yukata Niihara, e CEO and Chair of Emmaus life sciences Inc. USA, an internationally renowned doctor with over a dozen awards and citations, was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable Minister of State, Shri Arun Halder. This felicitation came as a recognition of Dr. Yuktaka Niihara’s work – the development of an FDA-approved drug ENDARI to fight the scrounge of Sickle cell syndrome worldwide. The event was hosted by Dr.Aditi Govatrikar, a famous Bollywood personality, and Miss World.

Over 20 million people in India suffer from sickle cell disease (SCD) due to genetic reasons. Tribal communities, in particular, are affected at a disproportionately high percentage and suffer exorbitantly because of being underprivileged and lack of resources. To ameliorate their condition and save hundreds of lives, it is vitally necessary to introduce this medication in India.

Dr.Niihara has tied up with an Indian Mumbai-based company, Akash Biomatrix Pvt. Ltd. represented by the undersigned to market and distribute this medicine in India at affordable prices. Emmaus Life sciences Inc of the USA is also seriously exploring setting up a manufacturing and Biotech research facility in India with an initial investment of over USD 300 million.

If you have any objection to this press release content, kindly contact pr.error.rectification[at]gmail.com to notify us. We will respond and rectify the situation in the next 24 hours

Health Tags:Healthcare

Post navigation

Previous Post: What Makes Honey the Most Natural Superfood and What Are Its Benefits?
Next Post: Gali Guleiyan: In the Shadows with Manoj Bajpai

Related Posts

  • Radhika Ayurveda: Guiding people on the path to holistic health and wellness Health
  • Expert Hernia Repair in Thrissur – Advanced Care by Dr. Arun S. Nair Health
  • Sakhiya Skin Clinic Introduces Apollo Duet for Advanced Skin Rejuvenation Health
  • Healing Hospital Chandigarh Achieves Groundbreaking Success in Sleep Apnea Surgery for High BMI Patient Health
  • Dr. GVP Rao- An Orientation to a Competent Medical Professional & a Kind Human Being! Health
  • Meyer Vitabiotics Makes History on World Osteoporosis Day, Secures Spot in Asia Book of Records Health

Recent Posts

  • Visva-Bharati Alumna Prantika Saha Creates Waves with a Bold Reimagining of Tagore’s Chitrangada for Today’s Youth
  • Mother’s Group of Schools from Odisha Excels in CBSE Class X Results 2025–26
  • Maharashtra Flat Owners Welfare Association Emerges, Pushes Brokerage-Free Housing
  • Key Difference Between Best Health Insurance and Basic Health Insurance Policy
  • Indore Child Psychologist Dr. Vini Jhariya Addresses the ‘Intelligent but Struggling’ Gap in Student Learning

Recent Comments

  • Unknown on Participants Reap Rewards in Wellman’s 8-Week Digital Campaign: IPL Tickets, Autographed Virat Kohli Merchandise, and More!
  • PVL 2025 Season 4 (Match 35): Goa Guardians qualify for semis after Delhi Toofans beat Kolkata Thunderbolts in five-set thriller Press Release
  • Yamini Jadhav, Eknath Shinde’s Dark Horse in Shiv Sena’s Lok Sabha Campaign National
  • MMAD Communications Unveils RBI-Approved Payment Aggregator Services Under New Brand “Mpay” Business
  • India’s largest football stadium turned into a 250-bed COVID hospital by AMRI Hospitals Business
  • From Kidney Failure to Motorcycle Crusade: Vinod’s 2000 km Ride for Organ Donation Awareness. Health
  • Introducing “Apna Maharashtra”: The Untold Stories of Inspiration and Culture Business
  • India’s Silent Wealth Builder: Why Every Portfolio Needs Bonds in 2025 Finance
  • From Snacks to Celebrations: The Camy & Celejor Story Business

Copyright © 2026 Daily News India.

Powered by PressBook News WordPress theme